HeraMED Limited (FRA:1I4)

Market Cap	30.70M +238.9%
Revenue (ttm)	245.20K -10.3%
Net Income	-2.35M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	77,995
Open	0.0210
Previous Close	0.0230
Day's Range	0.0210 - 0.0210
52-Week Range	0.0035 - 0.0535
Beta	n/a
RSI	47.78
Earnings Date	Feb 27, 2026

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Haw...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2011
• Country: Australia
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1I4

Financial Performance

In 2025, HeraMED's revenue was 431,605, a decrease of -10.31% compared to the previous year's 481,227. Losses were -4.13 million, -24.75% less than in 2024.

Financial numbers in AUD